Washington, DC, Sept. 26, 2017 -- This September 26 once again marks Mesothelioma Awareness Day. Mesothelioma is a cancer most people have seen in late-night commercials, but few know much about.
|
|||
The Mesothelioma Applied Research Foundation (Meso Foundation) is taking this opportunity to increase awareness of this cancer and educate the general public about its one main risk factor: asbestos.
Mesothelioma is a cancer usually associated with asbestos exposure. It is most often found in the lining of the lung or abdomen, and sometimes other organs as well.
The Meso Foundation states that it is a common misconception that asbestos has been banned or that regulations are in place to protect the public. In fact, they state, asbestos has still not been banned in the United States and while it is no longer manufactured here, it is still imported in a number of products. Although asbestos is regulated through workplace laws which help prevent occupational exposure, they do not protect the general public, as homes built between the 1940s and 1980s are likely to contain asbestos already (attic insulation, plaster, tiling, pipe insulation, etc…).
According to the organization, Do-It-Yourself-ers and “weekend renovators” are especially at risk when renovating or repairing homes and if doing the work in an occupied residence, all residents living in the home are at risk of inhaling microscopic asbestos fibers which are easily distributed throughout the home through HVAC system.
Mesothelioma can take between 20-50 years to develop from the time of inhalation of asbestos. The cancer is known as very aggressive and survival at five years from diagnosis is less than 10%.
However, for some patients appropriate treatment can greatly extend survival. Although the FDA approved only one treatment regimen for mesothelioma in 2004 (chemotherapy combination of Alimta/cisplatin), mesothelioma patients should be aware of all of their options many of which include surgery and experimental drugs (through clinical trials).
The Mesothelioma Applied Research Foundation can be a resource to those who have been diagnosed by helping them and their families navigate available treatment options, access treatment and clinical trials, and provide financial assistance. Mesothelioma patients who need help can contact Gleneara Bates, MSW, the organization’s Director of Research and Medical Outreach at (703) 879-3821 or [email protected].
Additional information can be found at www.curemeso.org.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/804ba210-e3e2-448d-8b1e-c400b1a4c3a4
Maja Belamaric Mesothelioma Applied Research Foundation 7038793822 [email protected]


Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
FDA Approves Mitapivat for Anemia in Thalassemia Patients
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 



